CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients

✍ Scribed by Vroling, L; Lind, J S W; de Haas, R R; Verheul, H M W; van Hinsbergh, V W M; Broxterman, H J; Smit, E F

• Book ID: 110000284
• Publisher: Nature Publishing Group
• Year: 2009
• Tongue: English
• Weight: 487 KB
• Volume: 102
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/sj.bjc.6605477